MBX Biosciences, Inc. (MBX)

NMS – Real Time Price. Currency in USD

36.98

-3.10 (-7.73%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-248K

-244K

-157K

-56K

Gross Profit

-248K

-244K

-157K

-56K

Operating expenses (excl. COGS)

-98M

-68M

-35M

-25M

Operating Income

-98M

-68M

-35M

-25M

Non-operating income, total

11M

-974K

Pretax income

-87M

-62M

-33M

-26M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-87M

-62M

-33M

-26M

MBX Biosciences, Inc. (MBX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

MBX Biosciences, Inc. (MBX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

MBX Biosciences, Inc. (MBX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

MBX Biosciences, Inc. (MBX)

Income Statement (Annual)

Income Statement (Annual)